Diethylstilboestrol versus Bicalutamide in Hormone Refractory Prostate Carcinoma: A Prospective Randomized Trial

Publisher： Karger

E-ISSN： 1423-0399|75|3|217-221

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.75, Iss.3, 2005-10, pp. : 217-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prednisone plus Gefitinib versus Prednisone plus Placebo in the Treatment of Hormone-Refractory Prostate Cancer: A Randomized Phase II Trial

By  

Oncology, Vol. 74, Iss. 3-4, 2008-08 ,pp. : 223-228

Karger

Access to resources Recommend Favorite

Oral Chemotherapy in Hormone-Refractory Prostate Carcinoma Patients Unwilling to Be Admitted to Hospital

By  

Urologia Internationalis, Vol. 83, Iss. 4, 2009-12 ,pp. : 452-457

Karger

Access to resources Recommend Favorite

PSA and Second-Line Therapy of Hormone Refractory Prostate Carcinoma

By  

Urologia Internationalis, Vol. 66, Iss. 3, 2001-04 ,pp. : 131-134

Karger

Access to resources Recommend Favorite

Prevention of Bone Mineral Loss by Zoledronic Acid in Men with Prostate Carcinoma Receiving Androgen Deprivation Therapy: A Prospective Randomized Trial in an Indian Population

By  

Current Urology, Vol. 2, Iss. 2, 2008-11 ,pp. : 79-86

Karger

Access to resources Recommend Favorite

High-Dose versus Low-Dose Cisplatin Chemotherapy plus Treosulfan in Epithelial Ovarian Carcinoma FIGO II–IV: Results of a Prospective Randomized Trial

By  

Oncology Research and Treatment, Vol. 23, Iss. 3, 2000-07 ,pp. : 232-238

Karger

Access to resources Recommend Favorite